Edmp Inc. lessened its stake in shares of Medtronic PLC (NYSE:MDT) by 1.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 54,841 shares of the medical technology company’s stock after selling 1,065 shares during the quarter. Medtronic PLC comprises 4.5% of Edmp Inc.’s investment portfolio, making the stock its 3rd biggest holding. Edmp Inc.’s holdings in Medtronic PLC were worth $4,867,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in the company. Jackson Grant Investment Advisers Inc. boosted its position in shares of Medtronic PLC by 0.3% during the 1st quarter. Jackson Grant Investment Advisers Inc. now owns 2,920 shares of the medical technology company’s stock worth $235,000 after purchasing an additional 9 shares in the last quarter. Triangle Securities Wealth Management boosted its position in shares of Medtronic PLC by 0.3% during the 2nd quarter. Triangle Securities Wealth Management now owns 4,396 shares of the medical technology company’s stock worth $390,000 after purchasing an additional 15 shares in the last quarter. Tarbox Group Inc. boosted its position in shares of Medtronic PLC by 0.4% during the 1st quarter. Tarbox Group Inc. now owns 5,180 shares of the medical technology company’s stock worth $417,000 after purchasing an additional 20 shares in the last quarter. Shufro Rose & Co. LLC boosted its position in shares of Medtronic PLC by 0.3% during the 1st quarter. Shufro Rose & Co. LLC now owns 10,381 shares of the medical technology company’s stock worth $836,000 after purchasing an additional 28 shares in the last quarter. Finally, Guardian Life Insurance Co. of America boosted its position in shares of Medtronic PLC by 0.6% during the 1st quarter. Guardian Life Insurance Co. of America now owns 5,288 shares of the medical technology company’s stock worth $426,000 after purchasing an additional 29 shares in the last quarter. 80.62% of the stock is currently owned by institutional investors.

In other news, EVP Bryan C. Hanson sold 12,000 shares of the business’s stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $88.57, for a total transaction of $1,062,840.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Omar Ishrak sold 140,407 shares of the business’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $81.63, for a total transaction of $11,461,423.41. Following the transaction, the chief executive officer now directly owns 668,503 shares of the company’s stock, valued at $54,569,899.89. The disclosure for this sale can be found here. 0.31% of the stock is owned by insiders.

Shares of Medtronic PLC (NYSE:MDT) traded up 0.21% during midday trading on Friday, hitting $79.70. 4,593,164 shares of the stock traded hands. Medtronic PLC has a 52 week low of $69.35 and a 52 week high of $89.72. The company’s 50-day moving average is $82.04 and its 200 day moving average is $83.67. The firm has a market capitalization of $107.96 billion, a PE ratio of 26.83 and a beta of 1.03.

Medtronic PLC (NYSE:MDT) last released its quarterly earnings data on Tuesday, August 22nd. The medical technology company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.04. Medtronic PLC had a net margin of 13.75% and a return on equity of 12.92%. The firm had revenue of $7.39 billion during the quarter, compared to analysts’ expectations of $7.44 billion. During the same period in the previous year, the company earned $1.03 earnings per share. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. Analysts anticipate that Medtronic PLC will post $4.77 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 20th. Stockholders of record on Friday, September 29th will be issued a dividend of $0.46 per share. The ex-dividend date is Thursday, September 28th. This represents a $1.84 annualized dividend and a dividend yield of 2.31%. Medtronic PLC’s payout ratio is 61.95%.

Several brokerages recently weighed in on MDT. BidaskClub raised shares of Medtronic PLC from a “buy” rating to a “strong-buy” rating in a research report on Saturday, June 17th. Zacks Investment Research cut shares of Medtronic PLC from a “hold” rating to a “sell” rating in a research report on Tuesday, September 12th. Cowen and Company reaffirmed an “outperform” rating and issued a $95.00 price target (up previously from $86.00) on shares of Medtronic PLC in a research report on Sunday, May 28th. CIBC reaffirmed a “buy” rating on shares of Medtronic PLC in a research report on Friday, May 26th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and issued a $103.00 price target on shares of Medtronic PLC in a research report on Thursday, August 3rd. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company’s stock. Medtronic PLC presently has an average rating of “Hold” and a consensus price target of $88.78.

TRADEMARK VIOLATION WARNING: This article was originally published by Daily Political and is the property of of Daily Political. If you are viewing this article on another publication, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this article can be read at https://www.dailypolitical.com/2017/09/23/edmp-inc-cuts-stake-in-medtronic-plc-mdt.html.

Medtronic PLC Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Institutional Ownership by Quarter for Medtronic PLC (NYSE:MDT)

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.